SEC Form 4 · accession 0001209191-19-009921
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon M Foster
Officer — Group President
Period of report
Feb 11, 2019
Accepted (ET)
Feb 13, 2019 · 8:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 11, 2019 | M | 40,000 | $22.95 | A | 84,492 | D | |
| Common Stock | Feb 11, 2019 | F | 18,696 | $138.66 | D | 65,796 | D | |
| Common StockF1 | Feb 12, 2019 | S | 11,640 | $139.6799 | D | 54,156 | D | |
| Common StockF2 | Feb 13, 2019 | S | 21,304 | $140.886 | D | 32,852 | D | |
| Common Stock | holding | — | — | — | 10,000 | I | By JMF Trust (Spouse and Robert Nagel, Co-Trustees) | |
| Common Stock | holding | — | — | — | 10,000 | I | By LCF Trust (Reporting Person, Trustee) | |
| Common Stock | holding | — | — | — | 36,133 | I | By 2016 GRAT (Spouse, Trustee) | |
| Common Stock | holding | — | — | — | 50,000 | I | By 2018 GRAT (Spouse, Trustee) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF3 | $22.95 | Feb 11, 2019 | M | 40,000 | D | — | Feb 8, 2022 | Common Stock | 40,000 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.51 to $139.88, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.76 to $141.32, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.